Table 3 Results of scintigraphic and biochemical parameters in CSA and TAC groups at 1-year control
Parameters (range, average ± SD) | Total (n = 38) | CSA at 1 year (n = 21) | TAC at 1 year (n = 17) | pvalue |
|---|---|---|---|---|
HEF (%) | 17 to 100 | 17 to 79 | 37 to 100 | <0.0001 |
62.8 ± 29.0 | 44.7 ± 18.4 | 85.2 ± 23.6 | ||
Bilirubin (μmol/l) | 3.0 to 146.0 | 4.0 to 146.0 | 3.0 to 142.0 | 0.88 |
18.5 ± 30.4 | 17.8 ± 29.9 | 19.4 ± 32.0 | ||
ALAT (μkat/l) | 0.2 to 3.9 | 0.2 to 3.0 | 0.2 to 3.9 | 0.13 |
1.1 ± 1.0 | 0.8 ± 0.7 | 1.3 ± 1.2 | ||
ASAT (μkat/l) | 0.3 to 3.0 | 0.3 to 2.4 | 0.3 to 3.0 | 0.38 |
0.9 ± 0.7 | 0.8 ± 0.5 | 1.0 ± 0.9 | ||
ALP (μkat/l) | 0.7 to 5.8 | 0.7 to 5.8 | 0.8 to 4.8 | 0.44 |
1.8 ± 1.0 | 1.9 ± 1.4 | 1.7 ± 1.0 | ||
GT (μkat/l) | 0.2 to 26.2 | 0.4 to 8.1 | 0.2 to 26.2 | 0.12 |
3.2 ± 5.1 | 2.1 ± 2.3 | 4.6 ± 7.0 | ||
Creatinine, (μmol/l) | 60.0 to 273.0 | 60 to 273.0 | 63 to 177.0 | 0.23 |
117.1 ± 44.6 | 124.9 ± 53.6 | 107.5 ± 28.7 | ||
Iohexol clearance, (ml/min/1.7 m2) | 6.4 to 91.0 | 18.0 to 78.0 | 6.4 to 91 | 0.33 |
51.3 ± 17.4 | 48.8 ± 16.0 | 54.4 ± 19.0 |